February 2, 2022 — The American College of Radiology (ACR) has designated Hackensack Meridian Mountainside Medical Center as a Lung Cancer Screening Center.
The ACR Lung Cancer Screening Center designation is a voluntary program that recognizes facilities that have committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer.
In order to receive this elite distinction, facilities must be accredited by the ACR in computed tomography in the chest module, as well as undergo a rigorous assessment of its lung cancer screening protocol and infrastructure. Also required are procedures in place for follow-up patient care, such as counseling and smoking cessation programs.
“The Lung Cancer Screening Program gives our community convenient access to exceptional cancer care, should they need it,” said Tim O’Brien, CEO at Mountainside Medical Center. “This designation reinforces our commitment to provide quality services while maintaining a consistent approach to patient care.”
Lung cancer screening with low-dose computed tomography scans (CT scans), and appropriate follow-up care, significantly reduces lung cancer deaths. The United States Preventive Services Task Force recommends screening of adults aged 55 to 80 years old who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Lung cancer is the nation’s leading cancer killer – taking the lives of more people each year than breast, colon and prostate cancers combined.
This screening is covered by Medicare and most private insurance plans for those who meet criteria. For more information: www.mountainsidehosp.com/lung
Related low-dose CT lung screening content:
Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm
Updated USPSTF Lung Cancer Screening Guidelines
September 12, 2024 
